Shareholder Rights Law Firm To Investigate Insys Therapeutics

Insys-TherapeuticsSAN DIEGO, Dec 12, 2013 — Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Insys Therapeutics, Inc. INSY -21.97% violated state or federal laws.

On December 12, 2013, after the markets closed, Insys Therapeutics revealed that it had received a subpoena from the Office of Inspector General of the Department of Health and Human Services (“HHS”) in connection with an investigation of potential violations involving HHS programs. The subpoena requests documents regarding Subsys(R), including Insys’ sales and marketing practices relating to the product.


Since this news announcement, shares of Insys Therapeutics have fallen 29% in after-market trading.

If you have information that could assist in this investigation, or if you are a Insys Therapeutics shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker ([email protected]) by email or by phone at 619-230-0063, Ext. 118.

Johnson & Weaver, LLP is a nationally recognized shareholders’ rights law firm. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit .

Scroll to Top